Temporal trends in hip fracture incidence, mortality, and morbidity in Denmark from 1999 to 2012. (4th March 2018)

• Record Type: Journal Article
• Authors: Jantzen, Christopher; Madsen, Christian M; Lauritzen, Jes B; Jørgensen, Henrik L
• Is Part Of: Acta orthopaedica. Volume 89:Number 2(2018)
• Page Start: 170
• Page End: 176
• Publication Date: 2018-03-04
• Subjects: Orthopedics -- Periodicals; 616.7005
• DOI: 10.1080/17453674.2018.1428436
• Languages: English
• ISSNs: 1745-3674

Abstract

Abstract : Background and purpose — While development in hip fracture incidence and mortality is well examined, none has yet looked at the temporal trends regarding prevalence of co-morbidities. Therefore we investigated changes in incidence of first hip fracture, co-morbidity prevalence, 30 day- and 1-year mortality in hip fracture patients in the Danish population during the period 1999 to 2012. Patients and methods — Patients >18 years admitted with a fractured hip in Denmark between 1996 and 2012 were identified with data for the period 1999–2012 being analyzed regarding prevalence of co-morbidities, incidence, and mortality. Results — 122, 923 patients were identified. Incidence in the whole population declined but sex-specific analysis showed no changes for men. For the whole study population, 30-day and 1-year mortality remained unchanged. Age at time of first hip fracture also remained unchanged. Of the included co-morbidities a decrease in prevalence of malignancy and dementia in women was found while there was an increase in the prevalence of all remaining co-morbidities, except hemi- or paraplegia for both sexes, rheumatic diseases for women, and for men diabetes with complications, myocardial infarction, AIDS/HIV, and malignancy. Interpretation — While hip fracture incidence declined for women it was unchanged for men; likewise, 30-day and 1-year mortality rates together with age at first fracture remained unchanged. When these results are compared with the relatively large increase in the prevalence of co-morbidities, it does not seem likely that the increased disease burden is affecting either the incidence or the mortality.